Search Content | UT Health San Antonio MD Anderson Cancer Center

Search Result for ""

Clinical Trial

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients with Refractory Advanced/Metastatic Colorectal Cancer (FRUITION)

This will be a multi-center, randomized phase II trial of fruquintinib + TAS-102 as compared to fruquintinib.

provider

Anne–Marie Langevin, MD Pediatric Hematology/Oncology, Pediatrics

provider

Sukeshi Patel Arora, MD Gastrointestinal Oncology, Geriatric Oncology

provider

Chul Ha, MD Radiation Oncology, Hematology-Oncology

provider

Virginia Kaklamani, MD, DSc Breast Oncology, Hematology Oncology

provider

Robert Svatek, MD Urologic Oncology, Urology

provider

Aaron Sugalski, DO Pediatric Oncology, Sarcoma Oncology

provider

Josephine Taverna, MD Thoracic Oncology, Hematology Oncology

provider

Eva Galvan, M.D. Radiation Oncology, Pediatric Radiation Oncology

provider

Anand Karnad, MD Hematology-Oncology, Medical Oncology